Clinical Safety

Patients receiving Roche’s divarasib lived a median of roughly 18 months in a Phase 3 lung cancer trial, compared with about 12 months among those receiving Krazati or Lumakras. That finding, presented at the European Society for Medical Oncology meeting, sits alongside encouraging results for a

A personalized cancer vaccine puts manufacturing directly on the patient’s treatment timeline. Each medicine needs its own production and testing pathway, with the link to its intended recipient preserved throughout. Healthcare organizations and drug developers need an operating model that handles

The transition to digital quality measurement removes the human ability to interpret context, making the precise timing of electronic admission orders a financial necessity. For decades, the emergency department has served as a critical barometer for the health of the entire hospital system, yet

With more than 80 percent of trial participants achieving clear or almost clear skin, nomelcitinib is positioning itself as a robust competitor in the psoriasis treatment landscape. The quest for a highly effective, oral, and safe treatment for autoimmune skin conditions has long been the primary

Ambient listening technology allows physicians to focus entirely on the person in front of them rather than a computer screen during sensitive medical exams. This shift marks a significant departure from the recent era where digital interfaces often felt like a barrier in the examination room. As

Synthesizing expertise from biomedical informatics and clinical medicine has led to an AI approach that mirrors the specific information needs of physicians. As medical facilities nationwide struggle with administrative burnout, the burden of documenting patient transitions remains one of the most